Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors

NCT02108782 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Gastrinoma
Glucagonoma
Insulinoma
Pancreatic Polypeptide Tumor
Recurrent Islet Cell Carcinoma
Somatostatinoma

Interventions

DRUG: dovitinib lactate
OTHER: pharmacological study
OTHER: laboratory biomarker analysis

Sponsor

Academic and Community Cancer Research United

Collaborators

[object Object]